AstraZeneca's Toprol XL First Once-Daily Beta Blocker Approved For CHF
Executive Summary
AstraZeneca's Toprol XL (metoprolol) is the first beta blocker approved for once-daily use for treatment of congestive heart failure.
You may also be interested in...
Roche Kytril Acquisition From SmithKline Strengthens Hospital Focus In U.S.
Roche's acquisition of the anti-emetic Kytril from SmithKline Beecham will build on Roche's strength in the U.S. hospital market.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials